Several studies have clarified the effect of the ubiquitin-proteasome pathway on the function of E2F1 and consequent tumour development 40, 50, 51, while posttranslational modification of E2F6 in HCC cells is poorly understood. The gene discussed is E2F6; the disease is hepatocellular carcinoma.